Treatment for Stimulant Use Disorders (TIP 33) Module 2 (3 hours)

Learning Objectives

Upon completion of this course, participants will be able to:

• Describe how the signs, symptoms, and harmful effects of stimulant use vary based on route of administration, dose, drug purity, and chronicity of use.
• Identify the serious medical complications associated with stimulant use, including cardiovascular disease, respiratory effects, and cerebrovascular dysfunction.
• Explain the mechanisms of muscular and renal toxicity, gastrointestinal complications, and infectious disease risks associated with stimulant use.
• Describe the psychological complications of stimulant use disorders, including stimulant-induced psychosis, aggression, and violence.
• Analyze the relationship between stimulant intoxication, withdrawal, and the presentation of medical and psychiatric symptoms.
• Apply clinical assessment strategies to identify and manage the medical and mental health complications of stimulant use in treatment settings.

John Tinsley

John Tinsley

Ph.D.

Dr. John H. Tinsley is a former assistant professor of Medical Physiology at the Texas A&M University System College of Medicine. He received his Ph.D. from Texas A&M University, College Station, Texas; M.S. from the University of North Carolina; and his B.S. from the University of Oklahoma.

He has been teaching, training, consulting and conducting research in the fields of Medical Physiology and Behavioral Biology for over twenty-nine years. Dr. Tinsley has authored over twenty-five professional and refereed articles, including invited reviews. He has been a member of the American Society for Physiology, and work done in 2001 led to an international award from The European Society on Microcirculation. Dr. Tinsley has received research funding from the Veteran’s Administration, American Heart Association, and Scott and White Hospital. In addition, he has served on numerous review committees for national grant-funding agencies and scientific journals.

Approved and Widely Recognized

CEU Matrix is approved by the following national and state accreditation boards:

Provider #6310
Provider #94564

CEU Matrix is approved with the following state boards:

Arkansas (ASACB), California (CCAPP #OS-07-394-0222), California (CADTP #250), Connecticut (#0115-5202), Delaware (DCB #37), Florida (FCB #5141-A), Georgia (ADACBGA #2026-4-003), Illinois (IAODAPCA #19345), Kentucky, Louisiana (LA ADRA #E026), Michigan (MCBAP), Missouri (Missouri CB #183), New Mexico (NMCBBHP #2046), North Carolina (NCSAPPB), Ohio (OCDP #50-19236), Oklahoma (OBLADS #20260153), Texas (TCB #1758-07)

Recently Viewed

Ohio LICDC partial
$313.00
Ohio 30
$210.00
LA CIT
$221.00
Scroll to Top